These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1593 related articles for article (PubMed ID: 34169443)

  • 41. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
    Li Z; Liu T; Yang N; Han D; Mi X; Li Y; Liu K; Vuylsteke A; Xiang H; Guo X
    Front Med; 2020 Oct; 14(5):533-541. PubMed ID: 32367431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
    Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
    CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.
    Lingor P; Demleitner AF; Wolff AW; Feneberg E
    J Neural Transm (Vienna); 2022 Sep; 129(9):1155-1167. PubMed ID: 35434769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.
    Orsini A; Corsi M; Santangelo A; Riva A; Peroni D; Foiadelli T; Savasta S; Striano P
    Neurol Sci; 2020 Sep; 41(9):2353-2366. PubMed ID: 32767055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurological involvement in the respiratory manifestations of COVID-19 patients.
    Tan BH; Liu JM; Gui Y; Wu S; Suo JL; Li YC
    Aging (Albany NY); 2021 Feb; 13(3):4713-4730. PubMed ID: 33582654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 associated nervous system manifestations.
    Khatoon F; Prasad K; Kumar V
    Sleep Med; 2022 Mar; 91():231-236. PubMed ID: 34321155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2: is there neuroinvasion?
    McQuaid C; Brady M; Deane R
    Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
    Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
    Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The myocardial and neuronal infectivity of SARS-CoV-2 and detrimental outcomes.
    Herbert E; Fournier D; Al-Shaqha WM; Chahine M
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1128-1136. PubMed ID: 34546143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19.
    Pantelis C; Jayaram M; Hannan AJ; Wesselingh R; Nithianantharajah J; Wannan CM; Syeda WT; Choy KC; Zantomio D; Christopoulos A; Velakoulis D; O'Brien TJ
    Aust N Z J Psychiatry; 2021 Aug; 55(8):750-762. PubMed ID: 32998512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Putative mechanism of neurological damage in COVID-19 infection.
    Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
    Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V
    Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurologic Manifestations and Complications of COVID-19.
    Hensley MK; Markantone D; Prescott HC
    Annu Rev Med; 2022 Jan; 73():113-127. PubMed ID: 34416121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does COVID-19 contribute to development of neurological disease?
    Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
    Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications.
    Kalra RS; Dhanjal JK; Meena AS; Kalel VC; Dahiya S; Singh B; Dewanjee S; Kandimalla R
    Front Aging Neurosci; 2021; 13():662786. PubMed ID: 34149397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.